Join BOPA
Back to news articles

New Recordings NOW available

By BOPA on 23rd November 2024

The recordings of the UK BMT Pharmacists Group Educational Meeting June 2024 is now available to watch via this link:

UK BMT Pharmacists Group Educational Meeting Series (June 2024)

 

The recordings of the following webinars are also available to watch on the BOPA website:

My Research Webinar 20 – Understanding global participation in gynae-oncology RCTs: a systematic review approach (25/09/2024)
My Research Webinar 19 – Real world experience of bispecific antibody in RRMM & Survey on understanding the gaps in SACT education to minority group cancer patients (25/04/2024)
My Research Webinar 18 – Interventions in Early Phase Clinical Trials & My DPharm Journey (20/03/2024)
Explore what ISOPP can do for you (27/02/2024)

 

All BOPA Webinars can also be found under the Resources Section on the website, filtered under webinars (https://www.bopa.org.uk/resources/?_sft_resource-type=webinar)
Note: Paid memberships are required for some recordings.

Latest News

By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article
By BOPA Committee on 27th April 2025

Women for Oncology UK Spring Webinar

The Spring webinar for Women for Oncology UK is on the 16th May, to sign up click the link below. Women For Oncology UK Spring Webinar Tickets, Wed 14 May…

Read article
By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article